OR WAIT null SECS
July 09, 2025
Article
The first half of 2025 recap for nephrology spotlights renal FDA action, ERA 2025 Congress coverage, and updates in xenotransplantation.
July 08, 2025
Positive topline results showed patients who received 2 scheduled rilparencel injections experienced significant eGFR slope decline improvement.
July 05, 2025
The Q2 recap for nephrology spotlights key FDA decisions and top coverage from the 62nd European Renal Association Congress.
July 02, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from June 2025.
The month in review spotlights renal regulatory news and clinical trial data as well as coverage of the 62nd European Renal Association Congress.
June 30, 2025
The CRL cited deficiencies previously identified at a third-party manufacturing vendor unrelated to OLC, and the Company plans to request a Type A meeting.
June 25, 2025
Video
From new data for potential IgAN treatments to the use of combination initiation therapy for type 2 diabetes and CKD, here are 5 key updates from the annual meeting.
June 22, 2025
A global study reveals that universal access to semaglutide could save 28 million lives and significantly reduce obesity and diabetes worldwide.
June 20, 2025
Investigators also noted the risk of Hb overshoot in patients switching from ESA to roxadustat, emphasizing the importance of monitoring Hb levels before and after treatment.
June 10, 2025
A recap of 3 Kidney Compass podcast episodes recorded at ERA 2025, including summaries and preview clips.
